BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Down 60.3% in February

BiomX Inc. (NYSEAMERICAN:PHGE) was the target of a significant decline in short interest in February. As of February 15th, there was short interest totalling 9,800 shares, a decline of 60.3% from the January 31st total of 24,700 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average daily volume of 86,000 shares, the short-interest ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, HC Wainwright reaffirmed a “buy” rating and set a $2.00 target price on shares of BiomX in a research report on Wednesday, January 8th.

BiomX Stock Down 4.4 %

Shares of NYSEAMERICAN:PHGE traded down $0.03 during trading on Friday, reaching $0.65. 40,479 shares of the company’s stock traded hands, compared to its average volume of 75,523. BiomX has a 12 month low of $0.48 and a 12 month high of $8.55. The company has a market cap of $11.82 million, a PE ratio of -0.20 and a beta of 1.27.

About BiomX

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).